As weight-gain and metabolic abnormalities during treatment with psychotropic drugs are of great concern, we evaluated effects of psycho-education and medical monitoring on metabolic changes among severely mentally ill patients
Background: second-generation (\u201catypical\u201d) antipsychotics are widely used for the treatmen...
5Background: second-generation (“atypical”) antipsychotics are widely used for the treatment of bipo...
Background: Antipsychotic-induced weight gain (AIWG) and other adverse metabolic effects represent s...
Purpose: As weight-gain and metabolic abnormalities during treatment with psychotropic drugs are of ...
To examine the metabolic profile of adolescents at baseline and to determine the potential predictiv...
To examine the metabolic profile of adolescents at baseline and to determine the potential predictiv...
Objectives: To review current evidence for the hypothesis that treatment with antipsychotic medicati...
PURPOSE: To describe the weight gain-related side-effects of psychotropic drugs and their consequenc...
Objective: To explore changes in eating behaviours, inherent weight gain and the metabolic consequen...
Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated w...
Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated w...
Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated w...
Patients suffering from schizophrenia have an elevated risk for obesity and metabolic syndrome due t...
Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated w...
Patients suffering from schizophrenia have an elevated risk for obesity and metabolic syndrome due t...
Background: second-generation (\u201catypical\u201d) antipsychotics are widely used for the treatmen...
5Background: second-generation (“atypical”) antipsychotics are widely used for the treatment of bipo...
Background: Antipsychotic-induced weight gain (AIWG) and other adverse metabolic effects represent s...
Purpose: As weight-gain and metabolic abnormalities during treatment with psychotropic drugs are of ...
To examine the metabolic profile of adolescents at baseline and to determine the potential predictiv...
To examine the metabolic profile of adolescents at baseline and to determine the potential predictiv...
Objectives: To review current evidence for the hypothesis that treatment with antipsychotic medicati...
PURPOSE: To describe the weight gain-related side-effects of psychotropic drugs and their consequenc...
Objective: To explore changes in eating behaviours, inherent weight gain and the metabolic consequen...
Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated w...
Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated w...
Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated w...
Patients suffering from schizophrenia have an elevated risk for obesity and metabolic syndrome due t...
Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated w...
Patients suffering from schizophrenia have an elevated risk for obesity and metabolic syndrome due t...
Background: second-generation (\u201catypical\u201d) antipsychotics are widely used for the treatmen...
5Background: second-generation (“atypical”) antipsychotics are widely used for the treatment of bipo...
Background: Antipsychotic-induced weight gain (AIWG) and other adverse metabolic effects represent s...